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Abstract
Background: We assessed the metrics used in claims about disease importance made in the introductory sections
of scientific papers published in 1993 and 2003. We were interested in the choice of metric in circumstances
where establishing the relative social importance of a disease was, presumptively, a primary objective.
Methods: This study consisted of a textual examination of the introductory statements from papers retrieved from
MEDLINE. Papers were published in the New England Journal of Medicine, The Lancet, and the Journal of the
American Medical Association during the first halves of 1993 and 2003, and were selected on the basis of keywords
found in a pilot study to be associated with claims about disease importance.
Results: We found 143 papers in 1993 and 264 papers in 2003 included claims about disease importance in their
introductory sections, and characteristics of these claims were abstracted. Of the quotes identified in the papers
and articles examined, most used counts, prevalence, or incidence measurements. Some also used risk estimates
and economic quantities to convey the importance of the disease. There was no change in the types of metrics
used between 1993 and 2003. Very few articles, even in 2003, used metrics that weighted disease onsets by the
expected consequent loss of healthy time – such as years of life lost, quality-adjusted life years, and/or disability-
adjusted life years.
Conclusions: Claims about the relative importance of diseases continued to be overwhelmingly expressed in
terms of counts (of deaths and disease onsets) and comparisons of counts, rates, and risks. Where the aim is to
convey the burden that a given disease imposes on a society, “event-based” metrics might be less fit for the
purpose than “time-based” metrics. More attention is needed to how the choice of metric should relate to the
purpose at hand.
Background
Ranking diseases by their social importance is a central
analytic task in health policymaking. Of the many ways
in which the occurrence of disease may be measured
and expressed, some are more suitable for this purpose
than others. Although measures based on disease onsets
("event-based measures”) may be optimal for scientific
purposes, measures of the consequences of disease
onsets generally serve better as measures of the burden
that the disease imposes on society. Measures of disease
burden are therefore typically expressed in life or
healthy time lost. An example, using only mortality data,
is the metric of “years of life lost” [1,2].
The 1990s saw a new wave of interest in measures
designed to capture the social losses consequent to dis-
ease onset. In particular, the ambitious Global Burden
of Disease (GBD) initiative devised the disability-
adjusted life year (DALY), which first came to general
notice in the 1993 World Development Report.W ew e r e
interested to know whether the introduction of the
DALY and the growing literature on population health
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express the relative social importance of diseases.
In the introduction section of research reports,
researchers commonly justify their research topic by
making claims about the social importance of the dis-
ease under consideration. We have therefore searched
for these claims of disease importance in a sample of
papers drawn from three leading medical journals in
two periods spanning the introduction of the DALY.
Further analysis was conducted to assess the extent of
the usage of the DALY in the scientific literature
indexed on MEDLINE over a longer time period.
Methods
We selected three high-impact general medical journals:
the New England Journal of Medicine,t h eJournal of the
American Medical Association, and The Lancet.W ec o n -
ducted a pilot study to identify search terms that would
be likely to be included in papers with claims of interest.
We chose the study periods Jan. 1, 1993 to June 30, 1993
and Jan. 1, 2003 to June 30, 2003 to straddle the period
of the introduction of new examples of time-based
metrics - notably the DALY. Our search in PubMed was
limited to original contributions, articles, reviews, and
editorials dealing with humans, and article type was
restricted to clinical trial, editorial, meta-analysis, review,
classical article, comparative study, and journal article.
We downloaded all hits to Endnote for further
exploration. First, a search for keywords in Endnote was
conducted to identify papers likely to include claims of
interest. Keywords included epidemiology, statistics and
numerical data, morbidity, mortality, risk, prevalence,
incidence, trial (type of work), review (type of work),
and etiology. Keywords used to filter out papers unlikely
to contain claims of interest included: patient satisfac-
tion, conflict of interest, confidentiality, health services,
organization and administration, ethical committee, bio-
medical research, drug industry, legislation and jurispru-
dence, malpractice, medical error, case report, altruism,
empathy, medical records, physician-patient relations,
Hippocratic oath, criminal law, abstracting and indexing,
wit and humor, attitude to health, biography, historical
article, and social control. The titles of the remaining
articles were scanned to identify papers that were
focused on specific diseases. Claims about the impor-
tance of a disease were extracted and analyzed. We dis-
tinguished three main groups of metrics:
1. Objective (excluding time-based). This included
counts, proportions, risks, and rates. Additionally,
we included rankings based on these metrics, e.g., “X
is the second leading cause of death"; “Anxiety and
panic disorders are approximately twice as frequent
among women as among men.”
2. Economic. This included measures when disease
occurrence was expressed in terms of cost or utility
(derived from the theoretical framework of econom-
i c s )b u tw a sn o tt i m e - b a s e d ,e . g . ,d i r e c tt r e a t m e n t
costs.
3. Time-based. This class of measures was typically
designed to convey the losses of life or of healthy
time consequent to disease onsets. These measure
were usually based on life table methodologies, e.g.,
years of life lost (mortality only) and the quality-
adjusted life year (QALY) or the DALY (incorporat-
ing mortality and morbidity).
Statements and claims
Each statement retrieved could include more than one
eligible claim. For example, three claims were taken
from the text below.
“Stroke is the third leading cause of death and a
major cause of disability in the United States. In
1999, 167,366 deaths in the United States resulted
from stroke. Approximately 30% of stroke survivors
are permanently disabled and 20% require institutio-
nalized care. Stroke is also a huge financial burden
for patients, their families, and the health care sys-
tem. The cost of stroke in the United States in 2002
is estimated to be $49.4 billion, which includes direct
health expenditures and lost productivity resulting
from morbidity and mortality.” [3]
These claims were classified as follows:
“Stroke is the third leading cause of death” - classi-
fied as an objective (rank) measure. “167,366 deaths
in the United States resulted from stroke” - classified
as an objective (count) measure.
“Approximately 30% of stroke survivors are perma-
nently disabled and 20% require institutionalized
care” - Two objective (proportional) measures,
admittedly with an implied time dimension.
To provide a broader overview of the extent of uptake
of the DALY, we searched MEDLINE for all citations of
the DALY over the 16 years from its introduction in
1993 until 2009. The search was conducted using the
following search terms:
1. “disability adjusted life year*”
2. DALY*
* Asterisks refer to a wildcard search operator
The term “DALY” in the author and address fields was
excluded from the search. The titles and abstracts of the
retrieved articles were scanned and categorized
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analysis. We found that the context in which the DALY
was used could be categorized into three broad groups:
1) economic and evaluative research, in which the main
purpose of the paper was to estimate a cost per DALY
or to assess a technology or intervention in terms of
DALYs averted; 2) assessment of the burden from one or
more diseases, where the research was focused upon
estimating the amount of disease in a population; and 3)
methodological, where attention was focused on the
strengths and weaknesses of the metric.
Results
We found 143 papers in 1993 and 264 papers in 2003
that made one or more eligible claims in their introduc-
tory sections, yielding 349 claims in 1993 and 660 in
2003 (Figure 1).
The majority of the claims in 1993 and 2003 used
objective metrics, including counts and proportions, to
express the importance of the disease of interest. Some
also used risk estimates and relative terms that stated
disease effects in a population in relation to other dis-
eases or from the same disease in other populations.
Economic quantities, such as cost of treatment, were
used in fewer than 5% of the claims, while time-based
metrics were rarely employed. In 1993, one article
expressed total years of potential life lost (YPLL) in the
US and indicated the proportional contribution of differ-
ent diseases and conditions to this total. In 2003, one
article used the DALY to express the burden of cardio-
vascular disease in more and less developed countries,
while another employed the QALY in four statements to
compare the relative cost effectiveness of surgery versus
medical therapy for people with severe emphysema.
Most of the objective measures used were proportions
and counts, while a substantial number were rates and
rank measures. There was no significant change in the
number of rates, risk, and relative measures used
between 1993 and 2003 (p-value = 0.99) (Table 1).
Those claims that expressed the importance of a pro-
blem by rank were most likely to use cause of death or
membership in a grouping of diseases as the basis for
ranking, e.g., “Lung cancer is the most common form of
cancer” (Table 2). Very few authors ranked the impor-
tance of their disease as a cause of morbidity or by
time-based measures.
PubMed search for DALY
The number of journal articles using the DALY metric
increased gradually from 1994, reaching a maximum of
85 citations in 2007. A total of 279 papers over the 16
years were concerned with directly assessing the burden
of one or more diseases. Alternatively, the DALY was
used to express the burden of a disease of interest as
background to the research presented. More than one-
third of all papers (242 out of a total of 627 papers) used
the DALY in the context of evaluations. While the num-
ber of DALY citations in burden assessments has been
steady at an average of 30 articles a year, citations using
the DALY metric for economic analyses have seen an
increased use over recent years (Figure 2). The Bulletin of
Figure 1 Schematic representation of articles retrieved from
three leading medical journals through a MEDLINE search and
the number of articles resulting from the selection process.
Table 1 Distribution of the different types of metrics
Measure 1993 (n = 349)
N (% of all)
2003 (n = 660)
N (% of all)
Objective metrics 336 (96.5) 628 (95.2)
Proportions 126 (36.3) 264 (40)
Counts 102 (29.4) 143 (21.7)
Rates 47 (13.5) 118 (17.9)
Rank 38 (10.7) 54 (8.2)
Relative measures 13 (3.9) 42 (6.4)
Risk 10 (2.9) 7 (1.1)
Economic metrics 12 (3.5) 26 (3.9)
Time-based metrics 1 (0.2) 6 (0.9)
Table 2 Distribution of the different types of ranking
measures
1993 (n = 36)
N (% of all ranked)
2003 (n = 53)
N (% of all ranked)
Cause of death 18 (48.6) 19 (34)
Cause of morbidity 1 (2.7) 4 (7.5)
Cause of disease 7(18.9) 5 (9.4)
’Most common form of...’ 7 (18.9) 20 (37.7)
Burden/years of life lost 1 (2.7) 3 (5.7)
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for papers using the DALY. Citations that reflected on
the use or calculation of the DALY peaked in 2000. Prior
to and after 2000, such papers averaged about four per
year and seven per year, respectively.
As a proportion of the total number of records in
PubMed, total DALY citations ranged from 0.1% in
1994 to 0.97% in 2009, showing a similar pattern of
rises and falls in different years as seen in Figure 2 (data
not shown).
Discussion
In the materials reviewed, over the time period of inter-
est, we found that there has been limited use of time-
based metrics when making claims about the impor-
tance of diseases. This was not because the metrics
actually used were always adequate for the purpose at
hand. For example, counts were often used even though
this metric left the reader with little guidance on how to
interpret the magnitude that was being conveyed (i.e., is
100,000 road traffic deaths a large or small number?).
The import of different rates of change may also be
challenging for the reader.
Why then is there little evidence of a trend toward
time-based metrics for conveying disease burdens?
There are several possibilities:
￿ When making claims, researchers may not con-
sider the choice of metric to be a matter of any
consequence.
￿ Researchers may be unconvinced of the relative
merits of time-based versus event-based metrics for
this purpose.
￿ Journal editors may not favor the use of time-
based metrics.
A number of studies have demonstrated that the rank
position of a disease can be very sensitive to the mea-
sure used [4-7]. Policymakers and others seeking infor-
mation for prioritization purposes will be better served
Figure 2 The number of journal articles citing the DALY and the nature of its use from 1994 to 2009.
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appropriate to the purpose at hand. Although it is unli-
kely that the claims made in the introductory section of
scientific reports will be used to make important policy
decisions, the apparent lack of attention afforded these
claims may be indicative of a broader neglect afforded
to the choice of metrics when expressing disease bur-
den. “All measures of population health involve choices
and value judgments in both their construction and
their application” [8]. This is as true for seemingly sim-
ple metrics such as death counts as it is for complex
summary measures like the DALY.
One limitation of the first part of this study is that we
restricted our analysis to three leading general medical
journals. Use of time-based measures may be more pro-
minent in specialized journals. Indeed, in our broad
search for citations of the DALY, 23 articles picked up
from statements in the introductory section of articles
were commonly from parasitology and mental health
journals as well as the Bulletin of the WHO (data not
shown). Our interest here, however, was in assessing the
spread of the practice, and leading general journals were
considered an appropriate starting point.
The second part of our study assessed trends in the
uptake of the DALY itself in the whole of the scientific
literature indexed in MEDLINE. DALY usage itself has
seen some increased use over the past decade. A second
limitation of this study concerns the search terms used
for this analysis. Our search was limited to the terms
“DALY” and “disability adjusted life years.” A broader
search would have extended the terms used to include
such phrases as “burden of disease.” Some authors, for
example, rather than report DALYs directly, may repre-
sent their calculations as a proportion of the total bur-
den. On the other hand, “burden of disease” does not
necessarily refer to burden as measured by the DALY or
any other time-based metric. Furthermore, in many
publications, it is not clear what is implied by burden.
For these reasons, and for the purposes of this paper, it
was felt that an analysis of direct citations of the DALY
would provide an adequate understanding of the utiliza-
tion of the concept rather than the broader and opaque
concept of burden.
Two points about the DALY are interesting to note.
First, much of the increase was in the context of eco-
nomic assessments. Second, critical engagement with
the metric and related metrics peaked in 2000 and has
since stagnated. This seems to suggest that the DALY
has found a niche where its application is seen to be
less controversial.
This paper does not aim to suggest that the DALY, or
any other time-based metric, is the only (or even the
more) suitable metric for the purpose of informing pol-
icy. What we have hoped to demonstrate is that the
DALY and other time-based metrics, which were
designed for the purpose of expressing burden of dis-
e a s e ,h a v en o tb e e nt a k e nu pi nc o m m o nc o n t e x t s
where it is desirable to communicate the burden of dis-
ease effectively. The use of the DALY is well-known to
be controversial and accompanied by many technical
and theoretical concerns, and this may be a reason for
researchers’ apprehension. We have shown here, how-
ever, that the current practices in expressing disease
burden in the context of opening statements in journal
articles are also limited, and metrics employed are often
not intuitively informative. In other words, the choice of
metric for expressing the burden of disease should be
more deliberate, choices should be carefully considered,
and reflection on this topic should not stagnate.
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